Equities analysts expect Docusign Inc (NASDAQ:DOCU) to report earnings of $0.04 per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Docusign’s earnings. The highest EPS estimate is $0.06 and the lowest is $0.04. Docusign reported earnings of $0.01 per share during the same quarter last year, which indicates a positive year over year growth rate of 300%. The firm is scheduled to report its next quarterly earnings results on Thursday, June 6th.
According to Zacks, analysts expect that Docusign will report full-year earnings of $0.19 per share for the current fiscal year, with EPS estimates ranging from $0.15 to $0.25. For the next year, analysts expect that the firm will post earnings of $0.37 per share, with EPS estimates ranging from $0.28 to $0.53. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for Docusign.
Docusign (NASDAQ:DOCU) last posted its earnings results on Thursday, March 14th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.01). The company had revenue of $199.73 million for the quarter, compared to analyst estimates of $193.63 million. Docusign had a negative return on equity of 86.06% and a negative net margin of 60.84%. The business’s revenue was up 34.2% on a year-over-year basis.
Shares of NASDAQ DOCU traded down $2.19 during mid-day trading on Wednesday, reaching $53.02. 61,383 shares of the company were exchanged, compared to its average volume of 2,157,404. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. The stock has a market cap of $9.38 billion and a PE ratio of -18.29. Docusign has a twelve month low of $35.06 and a twelve month high of $68.35.
In related news, insider Kirsten O. Wolberg sold 10,166 shares of Docusign stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $52.95, for a total transaction of $538,289.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Kirsten O. Wolberg sold 28,310 shares of Docusign stock in a transaction that occurred on Tuesday, January 22nd. The stock was sold at an average price of $46.10, for a total transaction of $1,305,091.00. The disclosure for this sale can be found here. Insiders have sold a total of 634,709 shares of company stock worth $31,633,278 over the last ninety days.
A number of large investors have recently bought and sold shares of DOCU. Sonora Investment Management LLC acquired a new stake in Docusign during the 1st quarter worth approximately $31,000. Private Capital Group LLC increased its position in shares of Docusign by 173.0% during the 4th quarter. Private Capital Group LLC now owns 819 shares of the company’s stock valued at $33,000 after purchasing an additional 519 shares during the last quarter. Parallel Advisors LLC grew its position in Docusign by 244.1% in the 4th quarter. Parallel Advisors LLC now owns 905 shares of the company’s stock valued at $36,000 after acquiring an additional 642 shares during the last quarter. Caz Investments LP grew its position in shares of Docusign by 86.6% during the 4th quarter. Caz Investments LP now owns 933 shares of the company’s stock worth $37,000 after buying an additional 433 shares in the last quarter. Finally, Legacy Advisors LLC purchased a new stake in shares of Docusign during the 1st quarter worth $38,000. Institutional investors and hedge funds own 53.26% of the company’s stock.
DocuSign, Inc provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals.
Featured Story: Purposes and Functions of the Federal Reserve
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.